USA - NASDAQ:AHCO - US00653Q1022 - Common Stock
The current stock price of AHCO is 9.22 USD. In the past month the price decreased by -1.71%. In the past year, price decreased by -18.04%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
MCK | MCKESSON CORP | 20.71 | 86.25B | ||
COR | CENCORA INC | 18.72 | 56.23B | ||
CAH | CARDINAL HEALTH INC | 18.01 | 35.43B | ||
HSIC | HENRY SCHEIN INC | 14.68 | 8.29B | ||
AHG | AKSO HEALTH GROUP | N/A | 1.05B | ||
OMI | OWENS & MINOR INC | 3.4 | 383.11M | ||
WGRX | WELLGISTICS HEALTH INC | N/A | 115.16M | ||
ATPC | AGAPE ATP CORP | N/A | 66.01M | ||
COSM | COSMOS HEALTH INC | N/A | 28.59M | ||
VRAX | VIRAX BIOLABS GROUP LTD | N/A | 2.73M |
AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. The company is headquartered in Conshohocken, Pennsylvania and currently employs 10,500 full-time employees. The company went IPO on 2018-02-21. The firm provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home. Its product and service offerings include sleep therapy equipment, supplies, and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea; medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors and insulin pumps; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The company operates in 50 states through its network of over 670 locations in 47 states.
ADAPTHEALTH CORP
555 East North Lane, Suite 5075
Conshohocken PENNSYLVANIA 19462 US
CEO: Luke McGee
Employees: 10500
Phone: 16104244515
The current stock price of AHCO is 9.22 USD. The price increased by 1.21% in the last trading session.
The exchange symbol of ADAPTHEALTH CORP is AHCO and it is listed on the Nasdaq exchange.
AHCO stock is listed on the Nasdaq exchange.
14 analysts have analysed AHCO and the average price target is 13.39 USD. This implies a price increase of 45.2% is expected in the next year compared to the current price of 9.22. Check the ADAPTHEALTH CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ADAPTHEALTH CORP (AHCO) has a market capitalization of 1.25B USD. This makes AHCO a Small Cap stock.
ADAPTHEALTH CORP (AHCO) currently has 10500 employees.
ADAPTHEALTH CORP (AHCO) has a support level at 8.93 and a resistance level at 9.26. Check the full technical report for a detailed analysis of AHCO support and resistance levels.
The Revenue of ADAPTHEALTH CORP (AHCO) is expected to decline by -0.24% in the next year. Check the estimates tab for more information on the AHCO EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
AHCO does not pay a dividend.
ADAPTHEALTH CORP (AHCO) will report earnings on 2025-11-03, before the market open.
The PE ratio for ADAPTHEALTH CORP (AHCO) is 29.74. This is based on the reported non-GAAP earnings per share of 0.31 and the current share price of 9.22 USD. Check the full fundamental report for a full analysis of the valuation metrics for AHCO.
The outstanding short interest for ADAPTHEALTH CORP (AHCO) is 9.57% of its float. Check the ownership tab for more information on the AHCO short interest.
ChartMill assigns a technical rating of 2 / 10 to AHCO. When comparing the yearly performance of all stocks, AHCO is a bad performer in the overall market: 77.98% of all stocks are doing better.
ChartMill assigns a fundamental rating of 5 / 10 to AHCO. There are concerns on the financial health of AHCO while its profitability can be described as average.
Over the last trailing twelve months AHCO reported a non-GAAP Earnings per Share(EPS) of 0.31. The EPS increased by 122.46% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 2.29% | ||
ROA | 1.66% | ||
ROE | 4.73% | ||
Debt/Equity | 1.27 |
14 analysts have analysed AHCO and the average price target is 13.39 USD. This implies a price increase of 45.2% is expected in the next year compared to the current price of 9.22.
For the next year, analysts expect an EPS growth of 60.37% and a revenue growth -0.24% for AHCO